# FDA Inspection 1215468 - SM Biomed Sdn Bhd - July 28, 2023

Source: https://www.keypedia.com/records/fda_inspections/sm-biomed-sdn-bhd/f3c1bcad-8e07-4eaf-a1f8-5627732e953c
Source feed: FDA_Inspections

> FDA Inspection 1215468 for SM Biomed Sdn Bhd on July 28, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215468
- Company Name: SM Biomed Sdn Bhd
- Inspection Date: 2023-07-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1048456 - 2018-03-23](https://www.keypedia.com/records/fda_inspections/sm-biomed-sdn-bhd/3ddeecdc-630f-45aa-ae0d-b56b48862105)
- [FDA Inspection 972744 - 2016-03-11](https://www.keypedia.com/records/fda_inspections/sm-biomed-sdn-bhd/c8d086e0-7c87-4b30-b59e-a848dc00b5c2)
- [FDA Inspection 821162 - 2013-03-07](https://www.keypedia.com/records/fda_inspections/sm-biomed-sdn-bhd/5a509dfa-e556-4e9e-a9c1-44a549195699)

Company: https://www.keypedia.com/companies/sm-biomed-sdn-bhd/0a24751b-1943-43b7-982a-bfa2ec53ff2e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c